From July 1, 2022 to September 30, 2022, the company has repurchased 941,200 shares, representing 0.53% for BRL 24.83 million. With this, the company has completed the repurchase of 1,563,200 shares, representing 0.87% for BRL 39.9 million under the buyback announced on June 14, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.52 BRL | +1.78% | -1.50% | -35.95% |
07/05 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
20/03 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.95% | 365M | |
+38.89% | 723B | |
+34.21% | 595B | |
-2.92% | 369B | |
+19.78% | 332B | |
+2.01% | 282B | |
+16.96% | 244B | |
+9.50% | 208B | |
-4.99% | 205B | |
+0.90% | 168B |
- Stock Market
- Equities
- BLAU3 Stock
- News Blau Farmacêutica S.A.
- Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.